). This subdivision is based on the presence of protein antigens (Frasch and Gotschlich, 1974) rather than the group-specific polysaccharides, and it appears that these antigens are not confined exclusively to particular serogroups. The meningococci isolated from clinical infections in the UK are predominantly group B, and it seemed important to ascertain which serotypes are most prevalent. We have followed the typing system of Frasch and Chapman but, instead of their precipitin/bactericidal techniques, we have used bacterial agglutination. While this is not as refined as the original method, it is perhaps easier to perform on a number of strains and provides the essential epidemiological information.
Meningococci of group B and group C have been subdivided by serological typing schemes (Frasch and Chapman, 1972a and b;  Gold and Wyle, 1970 ). This subdivision is based on the presence of protein antigens (Frasch and Gotschlich, 1974) rather than the group-specific polysaccharides, and it appears that these antigens are not confined exclusively to particular serogroups. The meningococci isolated from clinical infections in the UK are predominantly group B, and it seemed important to ascertain which serotypes are most prevalent. We have followed the typing system of Frasch and Chapman but, instead of their precipitin/bactericidal techniques, we have used bacterial agglutination. While this is not as refined as the original method, it is perhaps easier to perform on a number of strains and provides the essential epidemiological information.
Methods

SERA
Strains of 11 serotypes (types 1, 2, 4, 5, 6, 7, 8, 9, 10, 11, 12) were kindly supplied by Dr Frasch and these strains were used to prepare antigens for the production of antisera in rabbits. Initially the criterion of adequate potency was the production of clear precipitin lines with antigenic extracts of the homologous strains (Frasch and Chapman, 1972b (Farries et al, 1975) , and Devon (Easton et al, 1974) , and representative strains from these outbreaks were provided by Dr Patricia Bradstreet.
Meningococcal strains unassociated with any clinical infections were obtained by culturing routine sputum specimens. These were plated on selective blood agar and incubated in a candle jar.
Sensitivity to sulphadiazine was estimated by methods described previously (Abbott and Graves, 1972 (Frasch and Chapman, 1973) . In addition, we have examined meningococci isolated from routine samples of sputum submitted to our laboratory, using these as a source of meningococci not associated with either sporadic or epidemic meningococcal infection. It was of interest that half these meningococci were group B, and type 2-associated meningococci formed only a small proportion (12%) of these strains. The result emphasizes the importance of the presence of type 2 antigen in strains that cause group B meningococcal disease. Examination of representative strains from outbreaks of meningococcal infection that have occurred in recent years showed that the serotype 2 was also associated with epidemic meningococcal disease in the UK. These findings, together with those published from the USA, confirm that most group B meningococcal infection is type 2-associated. The only other major element in the strains examined was the group that was untypable by the present technique.
When we examined sulphonamide sensitivity of the different serotypes we could detect no significant difference between the sensitivity of type 2 strains and the other types. This contrasts with the type 2 strains from the USA which are reported to have a slightly increased resistance to sulphonamide (Frasch and Chapman, 1973) . This difference presumably represents a geographical difference in the prevalence of sulphonamide sensitivity, and resistance is not, therefore, necessarily associated with the type 2 antigen.
In the development of vaccines against group B meningococci, antigens other than the group polysaccharide are clearly important. The serotype antigens appear to be highly immunogenic and stimulate the production of bactericidal and, presumably, also protective antibodies. Knowledge of the distribution of serotypes associated with disease will be advantageous when making the choice of antigens to be included in a vaccine.
